Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE), expanded its brand portfolio, releasing its most extensive suite of new products into the Canadian market to date.
Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that it intends to
Performance Food Group Co (NYSE: PFGC) reported Q4 FY23 sales growth of 1.9% Y/Y to $14.87 billion, missing the consensus of $15.07 billion.
Net sales benefitted from a positive channel mix, higher cases sold, and increased selling price per case due to inflation.